Early withdrawal of a treatment for patients with a rare kidney disease is possible without relapse, safer for patients and saves the NHS millions of pounds, new research has revealed.
A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist after new treatments.
New research published in Nature has uncovered powerful evidence that may explain why a new chemical modification of RNA is made in cells.
New research from The University of Toledo suggests that individuals with anemia may have a significantly higher risk of developing severe complications if they contract malaria. The findings were published this month in the peer-reviewed journal Infec…
Killer immune cells destroy cancer cells and cells infected by virus. These CD8+ T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic viral infection and cancer, the killer cells often lapse …
When the COVID pandemic hit, many people turned to the eerily prescient film “Contagion” (2011) for answers—or at least for catharsis. Suddenly, its hypothetical plot felt all too real. Applauded for its scientific accuracy, the film offered more than …
A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five years of follow-up, according to a study published in Nature Medicine.
A new discovery made by researchers from The Australian National University (ANU) could lead to smarter, more effective treatments for Hodgkin lymphoma, a common blood cancer.
UCSF researchers have found that certain antiviral genes become less active over time in lupus, revealing why some patients see their symptoms fade as they age.
The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk myelodysplastic syndrome (MDS), according to a study published online July 4 in the Journal of Clinical Medi…
